Q3 Earnings Alert: These are the most overvalued right nowSee Overvalued Stocks

Raymond James cuts Lam Research stock target, keeps Outperform rating

EditorNatashya Angelica
Published 10/15/2024, 10:14 AM
LRCX
-

On Tuesday, Raymond James adjusted its outlook on Lam Research (NASDAQ:LRCX) shares, a semiconductor company, by reducing its price target from $125.00 to $100.00. Despite the lower target, the firm maintained its Outperform rating on the stock. The revision reflects a downturn in the DRAM sector within China, as previously indicated by Applied Materials (NASDAQ:AMAT).

The analyst from Raymond James noted a reduction in the December 2024 quarterly estimates for Lam Research, citing the current DRAM slowdown in China. However, the firm remains positive on Lam Research's prospects due to several factors.

The valuation appears to factor in some of the risks to the near-term outlook, but growth in High Bandwidth (NASDAQ:BAND) Memory (HBM) and progress in Foundry/Logic, which represented 64% of the company's system sales in the June 2024 quarter, are seen as positives.

Looking to the future, the analyst expressed confidence in the opportunities presented by Taiwan Semiconductor Manufacturing Company's (TSMC) N2 node, which is expected to be a significant driver for Lam Research. Additionally, there is optimism regarding the NAND sector, with anticipated improvements in NAND utilization potentially leading to a recovery in Wafer Fabrication Equipment (WFE) spending in 2025.

Lam Research's stock performance will continue to be watched closely by investors as the company navigates the current industry challenges and capitalizes on the emerging opportunities outlined by Raymond James.

In other recent news, Lam Research Corporation (NASDAQ:LRCX), a key supplier of semiconductor manufacturing equipment, has reported significant revenue of $3.87 billion, exceeding analyst expectations. This is largely due to an increased demand for AI-powered chips. Additionally, the company announced a 15% increase in its quarterly dividend, raising it from $2.00 to $2.30 per share.

Morgan Stanley has adjusted its outlook on Lam Research, lowering its price target on the company's stock to $77.00, maintaining an Equalweight rating. Mizuho Securities also maintained an Outperform rating on Lam Research, despite a decrease in its price target from $1,050 to $950.

In other recent developments, Lam Research implemented a ten-for-one forward stock split and increased its authorized shares of common stock tenfold. The company also announced the upcoming departure of two board members in November 2024, and the appointment of industry veterans Ita Brennan and Mark Fields to its board of directors.

These recent developments highlight Lam Research's ongoing strategic growth and commitment to its investors.

InvestingPro Insights

Lam Research's financial metrics and market position offer additional context to Raymond James' outlook. Despite the reduced price target, InvestingPro data shows that Lam Research maintains a strong market presence with a market capitalization of $111.08 billion. The company's P/E ratio of 29.42 suggests investors are willing to pay a premium for its earnings, potentially reflecting confidence in its future growth prospects.

An InvestingPro Tip highlights that Lam Research is a "Prominent player in the Semiconductors & Semiconductor Equipment industry," aligning with the analyst's positive long-term view. This position could be advantageous as the industry navigates current challenges and looks towards future opportunities like TSMC's N2 node.

Another relevant InvestingPro Tip notes that Lam Research "Has raised its dividend for 10 consecutive years," with a current dividend yield of 1.07%. This consistent dividend growth may provide some stability for investors during market fluctuations and industry cycles mentioned in the article.

For readers interested in a deeper analysis, InvestingPro offers 11 additional tips for Lam Research, providing a more comprehensive view of the company's financial health and market position.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.